// App-Quantinova.ai

5703 : Oncologic therapy shapes the fitness landscape of clonal hematopoiesis

Researchers

Presenter

  • Kelly L. Bolton

Principal Investigators

  • Teng Gao

  • Lior Braunstein

  • Sean M. Devlin

  • Minal Patel

  • Antonin Berthon

  • Aijazuddin Syed

  • Mariko Yabe

  • Catherine Coombs

  • Nicole M. Caltabellotta

  • Mike Walsh

  • Ken Offit

  • Zsofia Stadler

  • Choonsik Lee

  • Paul Pharoah

  • Konrad H. Stopsack

  • Barbara Spitzer

  • Simon Mantha

  • James Fagin

  • Laura Boucai

  • Christopher J. Gibson

  • Benjamin Ebert

  • Andrew L. Young

  • Todd Druley

  • Koichi Takahashi

  • Nancy Gillis

  • Markus Ball

  • Eric Padron

  • David Hyman

  • Jose Baselga

  • Larry Norton

  • Stuart Gardos

  • Virginia Klimek

  • Howard Scher

  • Dean Bajorin

  • Eder Paraiso

  • Ryma Benayed

  • Maria Arcilla

  • Marc Ladanyi

  • David Solit

  • Michael Berger

  • Martin Tallman

  • Montserrat Garcia-Closas

  • Nilanjan Chatterjee

  • Luis Diaz

  • Ross Levine

  • Lindsay Morton

  • Ahmet Zehir

  • Elli Papaemmanuil

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • University of North Carolina, Chapel Hill, NC

  • University of Cambridge, Cambridge, United Kingdom

  • Dana-Farber Cancer Institute, Boston, MA

  • Washington University, St Louis, MO

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Moffitt Cancer Center, Tampa, FL

  • National Cancer Institute, Bethesda, MD

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • DNA methyltransferase 3 alpha

  • Tumor protein p53

  • Splicing Factor 3b Subunit 1

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved